InventisBio Co., Limited (SHA:688382)

InventisBio Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,174	1,381	1,586	1,919	2,235	724.25
Trading Asset Securities	152.96	153.68	101.3	-	-	-
Cash & Short-Term Investments	1,327	1,535	1,687	1,919	2,235	724.25
Cash Growth	-16.14%	-9.04%	-12.10%	-14.13%	208.62%	-29.90%
Accounts Receivable	86.04	84.67	165.34	176.57	-	-
Other Receivables	5.5	4.46	5.93	6.65	3.98	4.25
Receivables	91.54	89.12	171.28	183.21	3.98	4.25
Other Current Assets	42.54	27.52	11.69	20.46	26.28	12.95
Total Current Assets	1,461	1,651	1,870	2,123	2,265	741.45
Property, Plant & Equipment	26.65	30.07	44.82	30.38	47.14	44.02
Other Intangible Assets	0.84	1.43	0.59	0.92	1.25	0.11
Long-Term Deferred Tax Assets	2.64	3.19	3.44	2.9	6.22	-
Long-Term Deferred Charges	8.92	10.01	-	1.05	4.4	8.42
Other Long-Term Assets	21.74	7.92	1.86	3.9	23.35	6.02
Total Assets	1,522	1,704	1,921	2,162	2,348	800.03

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	75.88	115.48	59.96	72.52	62.25	64.22
Accrued Expenses	12.13	24.82	21.62	28.86	36.19	25.71
Current Portion of Leases	6.45	7.15	7.79	9	12.07	8.71
Current Unearned Revenue	-	-	-	47.17	-	-
Other Current Liabilities	1.1	1.45	0.61	0.72	0.51	0.22
Total Current Liabilities	95.56	148.9	89.98	158.27	111.02	98.85
Long-Term Leases	12.35	14.92	16.13	2.61	15.27	14.94
Long-Term Unearned Revenue	0.48	0.48	0.48	0.88	0.4	1.2
Long-Term Deferred Tax Liabilities	2.68	3.43	3.44	2.9	6.22	-
Total Liabilities	111.07	167.73	110.03	164.67	132.9	115

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	579.59	578.35	576.75	575	575	460
Additional Paid-In Capital	3,842	3,832	3,791	3,738	3,671	1,773
Retained Earnings	-2,999	-2,862	-2,545	-2,305	-2,021	-1,537
Comprehensive Income & Other	-11.9	-12.41	-11.9	-10.74	-10.4	-10.79
Shareholders' Equity	1,411	1,536	1,811	1,998	2,215	685.03
Total Liabilities & Equity	1,522	1,704	1,921	2,162	2,348	800.03

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	18.8	22.07	23.92	11.62	27.34	23.66
Net Cash (Debt)	1,309	1,513	1,663	1,908	2,208	700.6
Net Cash Growth	-16.14%	-9.06%	-12.82%	-13.59%	215.14%	-32.20%
Net Cash Per Share	2.27	2.63	2.91	3.32	4.34	1.53
Filing Date Shares Outstanding	579.59	578.35	576.75	575	575	460
Total Common Shares Outstanding	579.59	578.35	576.75	575	575	460
Working Capital	1,366	1,502	1,780	1,965	2,154	642.6
Book Value Per Share	2.43	2.66	3.14	3.47	3.85	1.49
Tangible Book Value	1,410	1,535	1,810	1,997	2,214	684.92
Tangible Book Value Per Share	2.43	2.65	3.14	3.47	3.85	1.49
Machinery	32.66	32.86	32.55	32.04	27.07	23.91
Construction In Progress	1.81	-	6.47	0.5	2.58	1.87

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error